Skip to Content

As a result of the current Federal government funding situation, the information on this website may not be up to date or acted upon.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at

Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Genome-wide association study identifies multiple loci associated with bladder cancer risk.
Authors: Figueroa JD,  Ye Y,  Siddiq A,  Garcia-Closas M,  Chatterjee N,  Prokunina-Olsson L,  Cortessis VK,  Kooperberg C,  Cussenot O,  Benhamou S,  Prescott J,  Porru S,  Dinney CP,  Malats N,  Baris D,  Purdue M,  Jacobs EJ,  Albanes D,  Wang Z,  Deng X,  Chung CC,  Tang W,  Bas Bueno-de-Mesquita H,  Trichopoulos D,  Ljungberg B,  Clavel-Chapelon F,  Weiderpass E,  Krogh V,  Dorronsoro M,  Travis R,  Tjřnneland A,  Brenan P,  Chang-Claude J,  Riboli E,  Conti D,  Gago-Dominguez M,  Stern MC,  Pike MC,  Van Den Berg D,  Yuan JM,  Hohensee C,  Rodabough R,  Cancel-Tassin G,  Roupret M,  Comperat E,  Chen C,  De Vivo I,  Giovannucci E,  Hunter DJ,  Kraft P,  Lindstrom S,  Carta A,  Pavanello S,  Arici C,  Mastrangelo G,  Kamat AM,  Lerner SP,  Barton Grossman H,  Lin J,  Gu J,  Pu X,  Hutchinson A,  Burdette L,  Wheeler W,  Kogevinas M,  Tardón A,  Serra C,  Carrato A,  García-Closas R,  Lloreta J,  Schwenn M,  Karagas MR,  Johnson A,  Schned A,  Armenti KR,  Hosain GM,  Andriole G Jr,  Grubb R 3rd,  Black A,  Ryan Diver W,  Gapstur SM,  Weinstein SJ,  Virtamo J,  Haiman CA,  Landi MT,  Caporaso N,  Fraumeni JF Jr,  Vineis P,  Wu X,  Silverman DT,  Chanock S,  Rothman N
Journal: Hum Mol Genet
Date: 2014 Mar 1
PubMed ID: 24163127
PMC ID: PMC3919005
Abstract: Candidate gene and genome-wide association studies (GWAS) have identified 11 independent susceptibility loci associated with bladder cancer risk. To discover additional risk variants, we conducted a new GWAS of 2422 bladder cancer cases and 5751 controls, followed by a meta-analysis with two independently published bladder cancer GWAS, resulting in a combined analysis of 6911 cases and 11 814 controls of European descent. TaqMan genotyping of 13 promising single nucleotide polymorphisms with P < 1 × 10(-5) was pursued in a follow-up set of 801 cases and 1307 controls. Two new loci achieved genome-wide statistical significance: rs10936599 on 3q26.2 (P = 4.53 × 10(-9)) and rs907611 on 11p15.5 (P = 4.11 × 10(-8)). Two notable loci were also identified that approached genome-wide statistical significance: rs6104690 on 20p12.2 (P = 7.13 × 10(-7)) and rs4510656 on 6p22.3 (P = 6.98 × 10(-7)); these require further studies for confirmation. In conclusion, our study has identified new susceptibility alleles for bladder cancer risk that require fine-mapping and laboratory investigation, which could further understanding into the biological underpinnings of bladder carcinogenesis.